Glaucoma Facility, Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
J Glaucoma. 2014 Sep;23(7):467-70. doi: 10.1097/IJG.0b013e3182946536.
To evaluate the optic disc topography after pan retinal photocoagulation (PRP) in diabetic retinopathy patients using confocal scanning laser ophthalmoscopy (HRT3).
Thirty eyes of 30 diabetic patients (non-insulin-dependent diabetes mellitus) underwent PRP for proliferative diabetic retinopathy. Subjects with glaucoma or family history of glaucoma, any coexisting neuroophthalmic disease, uveitis, retinal artery or vein occlusion, corneal opacity or lasered previously were excluded from the study. Optic nerve head (ONH) of these patients were evaluated by confocal scanning laser ophthalmoscopy (HRT3) at baseline, 3, and 6 months after completion of PRP.
There were 23 males and 7 females with a mean age of 51.8 years (36 to 67 y). The mean intraocular pressure was 13.1±2.57 mm Hg at baseline, 13.4±2.6 mm Hg at 3 months, and 13.3±2.2 mm Hg at 6 months (P=0.6). The global values of ONH parameters showed no significant change from baseline at 3 months. At 6 months, there was a significant increase in vertical cup:disc ratio (P=0.021), cup volume (P=0.036), mean cup depth (P=0.042), and maximum cup depth (P=0.05) as compared with baseline values.
PRP induces significant changes in the ONH in patients with diabetic retinopathy as measured with HRT3. This is an important consideration in the diagnosis and evaluation of progression in glaucoma patients with diabetic retinopathy who have undergone PRP.
使用共焦激光扫描检眼镜(HRT3)评估糖尿病视网膜病变患者全视网膜光凝(PRP)后的视盘地形图。
30 只眼 30 例糖尿病患者(非胰岛素依赖型糖尿病)因增生性糖尿病视网膜病变接受 PRP 治疗。排除青光眼或青光眼家族史、任何并存的神经眼科疾病、葡萄膜炎、视网膜动脉或静脉阻塞、角膜混浊或先前已激光治疗的患者。这些患者的视神经头(ONH)在 PRP 完成后基线、3 个月和 6 个月时通过共焦激光扫描检眼镜(HRT3)进行评估。
23 名男性和 7 名女性,平均年龄 51.8 岁(36 至 67 岁)。基线时平均眼压为 13.1±2.57mmHg,3 个月时为 13.4±2.6mmHg,6 个月时为 13.3±2.2mmHg(P=0.6)。ONH 参数的总体值与基线相比在 3 个月时没有显著变化。6 个月时,垂直杯盘比(P=0.021)、杯容积(P=0.036)、平均杯深度(P=0.042)和最大杯深度(P=0.05)与基线值相比有显著增加。
PRP 会导致糖尿病视网膜病变患者的 ONH 发生显著变化,这可以通过 HRT3 进行测量。这在对接受 PRP 治疗的有糖尿病视网膜病变的青光眼患者的诊断和进展评估中是一个重要的考虑因素。